DE602006014097D1 - Cgrp-rezeptorantagonisten - Google Patents
Cgrp-rezeptorantagonistenInfo
- Publication number
- DE602006014097D1 DE602006014097D1 DE602006014097T DE602006014097T DE602006014097D1 DE 602006014097 D1 DE602006014097 D1 DE 602006014097D1 DE 602006014097 T DE602006014097 T DE 602006014097T DE 602006014097 T DE602006014097 T DE 602006014097T DE 602006014097 D1 DE602006014097 D1 DE 602006014097D1
- Authority
- DE
- Germany
- Prior art keywords
- receptor antagonists
- cgrp receptor
- cgrp
- compounds
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64465005P | 2005-01-18 | 2005-01-18 | |
| PCT/US2006/001252 WO2006078554A2 (en) | 2005-01-18 | 2006-01-13 | Cgrp receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602006014097D1 true DE602006014097D1 (de) | 2010-06-17 |
Family
ID=36692743
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602006014097T Active DE602006014097D1 (de) | 2005-01-18 | 2006-01-13 | Cgrp-rezeptorantagonisten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7632832B2 (de) |
| EP (1) | EP1856100B1 (de) |
| JP (1) | JP2008526984A (de) |
| CN (1) | CN101103020B (de) |
| AT (1) | ATE466853T1 (de) |
| AU (1) | AU2006206718B2 (de) |
| CA (1) | CA2594940A1 (de) |
| DE (1) | DE602006014097D1 (de) |
| WO (1) | WO2006078554A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7659264B2 (en) * | 2004-10-07 | 2010-02-09 | Merck Sharp & Dohme Corp. | CGRP receptor antagonists |
| US7470679B2 (en) | 2006-05-02 | 2008-12-30 | Bristol-Myers Squibb Company | Constrained compounds as CGRP-receptor antagonists |
| US7470680B2 (en) | 2006-05-03 | 2008-12-30 | Bristol-Myers Squibb Company | Constrained compounds as CGRP-receptor antagonists |
| EP2024358B1 (de) * | 2006-05-09 | 2014-11-05 | Merck Sharp & Dohme Corp. | Substituierte spirocyclische cgrp-rezeptorantagonisten |
| KR20150081370A (ko) | 2006-07-10 | 2015-07-13 | 파이온 유케이 리미티드 | 속효형 벤조디아제핀 염 및 이의 중합체 형태 |
| EP2305647A1 (de) | 2009-09-18 | 2011-04-06 | PAION UK Limited | Verfahren zur Herstellung von 3-[(4S)-8-brom-1-methyl-6-(2-pyridinyl)-4 H-imidazo[1,2-a][1,4]benzodiazepin-4-yl]propionsäuremethylester oder das Benzensulfonatsalz davon und in diesem Prozess nützliche Verbindungen |
| EP2450039A1 (de) | 2010-11-08 | 2012-05-09 | PAION UK Ltd. | Dosierschema zur Sedierung mit CNS 7056 (Remimazolam) |
| CA2870123C (en) * | 2012-04-18 | 2021-02-23 | Contera Pharma Aps | Orally available pharmaceutical formulation suitable for improved management of movement disorders |
| AR094963A1 (es) | 2013-03-04 | 2015-09-09 | Ono Pharmaceutical Co | Reacción de oxidación excelente en el índice de conversión |
| CA3030089C (en) | 2016-07-11 | 2024-04-23 | Contera Pharma Aps | Pulsatile drug delivery system for treating morning akinesia |
| EP3366286A1 (de) | 2017-02-22 | 2018-08-29 | Johannes Keller | Verbindungen zur behandlung von sepsis |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1117662A1 (de) | 1998-09-30 | 2001-07-25 | Merck Sharp & Dohme Limited | Benzimdazolinylpiperidine als cgrp-liganden |
| DE602004027021D1 (de) | 2003-04-15 | 2010-06-17 | Merck Sharp & Dohme | Cgrp-rezeptorantagonisten |
| US7196079B2 (en) * | 2003-06-26 | 2007-03-27 | Merck & Co, Inc. | Benzodiazepine CGRP receptor antagonists |
-
2006
- 2006-01-13 EP EP06718339A patent/EP1856100B1/de active Active
- 2006-01-13 DE DE602006014097T patent/DE602006014097D1/de active Active
- 2006-01-13 US US11/795,678 patent/US7632832B2/en active Active
- 2006-01-13 CA CA002594940A patent/CA2594940A1/en not_active Abandoned
- 2006-01-13 AT AT06718339T patent/ATE466853T1/de not_active IP Right Cessation
- 2006-01-13 WO PCT/US2006/001252 patent/WO2006078554A2/en active Application Filing
- 2006-01-13 JP JP2007551403A patent/JP2008526984A/ja not_active Withdrawn
- 2006-01-13 CN CN2006800024029A patent/CN101103020B/zh not_active Expired - Fee Related
- 2006-01-13 AU AU2006206718A patent/AU2006206718B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008526984A (ja) | 2008-07-24 |
| EP1856100A4 (de) | 2009-04-15 |
| AU2006206718A1 (en) | 2006-07-27 |
| WO2006078554A2 (en) | 2006-07-27 |
| WO2006078554A3 (en) | 2007-04-05 |
| EP1856100B1 (de) | 2010-05-05 |
| US7632832B2 (en) | 2009-12-15 |
| ATE466853T1 (de) | 2010-05-15 |
| EP1856100A2 (de) | 2007-11-21 |
| CN101103020A (zh) | 2008-01-09 |
| CN101103020B (zh) | 2011-04-27 |
| US20080125413A1 (en) | 2008-05-29 |
| CA2594940A1 (en) | 2006-07-27 |
| AU2006206718B2 (en) | 2011-06-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE537170T1 (de) | Cgrp-rezeptorantagonisten | |
| ATE411323T1 (de) | Cgrp-rezeptorantagonisten | |
| ATE503755T1 (de) | Cgrp-rezeptorantagonisten | |
| DE602005020655D1 (de) | Carboxamid-spirolactam-cgrp-rezeptor-antagonisten | |
| TW200505903A (en) | CGRP receptor antagonists | |
| ATE466860T1 (de) | Cgrp-rezeptorantagonisten | |
| DE602004013563D1 (de) | Rantagonisten | |
| ATE466853T1 (de) | Cgrp-rezeptorantagonisten | |
| ATE516803T1 (de) | Aryl-spirohydantoin-cgrp-rezeptor-antagonisten | |
| ATE464305T1 (de) | Bicyclische anilidspirolactame als antagonisten des cgrp-rezeptors | |
| ATE537153T1 (de) | Arylspirolactamverbindungen als antagonisten des cgrp-rezeptors | |
| ATE535514T1 (de) | Carboxamid-spirohydantoin-cgrp-rezeptor- antagonisten | |
| ATE556060T1 (de) | Monocyclische anilidspirohydantoine als cgrp- rezeptorantagonisten | |
| WO2005013894A3 (en) | Benzodiazepine cgrp receptor antagonists | |
| ATE509019T1 (de) | Benzodiazepinspirohydantoine als cgrp- rezeptorantagonisten | |
| WO2006041830A3 (en) | Cgrp receptor antagonists | |
| ATE463245T1 (de) | Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten | |
| WO2005000807A3 (en) | Benzodiazepine cgrp receptor antagonists | |
| WO2007016087A3 (en) | Heterocyclic benzodiazepine cgrp receptor antagonists | |
| ATE507880T1 (de) | Cgrp-rezeptorantagonisten | |
| ATE518852T1 (de) | Tricyclische anilid-spirohydantoin-cgrp- rezeptorantagonisten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| R081 | Change of applicant/patentee |
Ref document number: 1856100 Country of ref document: EP Owner name: SCHERING CORPORATION, US Free format text: FORMER OWNER: MERCK SHARP & DOHME CORP., RAHWAY, US Effective date: 20121213 |
|
| R082 | Change of representative |
Ref document number: 1856100 Country of ref document: EP Representative=s name: ABITZ & PARTNER, DE Effective date: 20121213 |